Search Results
Dr. Essel Discusses Long-Term Bevacizumab in Ovarian Cancer
ASCO 2009: Bevacizumab and standard adjuvant chemotherapy
Dr. Jason Konner Discusses Bevacizumab in Ovarian Cancer
Dose-Dense Chemotherapy for Ovarian Cancer; Adding Bevacizumab
Approaching Frontline Therapy Options for Ovarian Cancer
Adjuvant therapy - Chemotherapy issues
Dr. Tew Evaluates Bevacizumab Treatment in Ovarian Cancer
Neoadjuvant Chemotherapy and Ovarian Cancer
Targeting VEGF in Advanced Ovarian Cancer
The effectiveness of bevacizumab (Avastin) and related trials
Dr. Hardesty on Bevacizumab/PARP Inhibitor Combination in Ovarian Cancer
18th ESGO: Clinical trials, ENGOT and use of bevacizumab against angiogenesis
